Yun Hong

Activation of IL-6R/JAK1/STAT3 Signaling Induces <i>De Novo</i> Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation

Sun Mi Kim, Oh-Joon Kwon, Yun Hong et al. · Molecular Cancer Therapeutics · 2012 · 194 citations · Full text

Irreversible Egfr Inhibitors, Cell Signaling, T790m Resistance Mutation +13

Distinct clinical features and outcomes in never‐smokers with nonsmall cell lung cancer who harbor <i>EGFR</i> or <i>KRAS</i> mutations or <i>ALK</i> rearrangement

Hye Ryun Kim, Hyo Sup Shim, Jin‐Haeng Chung et al. · Cancer · 2011 · 148 citations

A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes

Seungtaek Lim, Hyun Chang, M.J. Yoon et al. · Annals of Oncology · 2013 · 138 citations · Full text

Surgical Oncology, Phase Ii Trial, Medicine +7

Short‐term clinical evaluation of intralesional triamcinolone acetonide injection for ulcerative oral lichen planus

Juan Xia, Chunyang Li, Yun Hong et al. · Journal of Oral Pathology and Medicine · 2006 · 98 citations · Full text

Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab

Jingtao Luo, Yun Hong, Yang Lü et al. · Cancer Letters · 2016 · 97 citations · Full text

Oncology, Oncogenic Agent, Medicine +9